American Heart Association
Research Program Overview
The presentation details the funding opportunities available from the South Central
Affiliate of the American Heart Association. Applications are being accepted for the following SCA programs: Predoctoral
Fellowship, Postdoctoral Fellowship, Beginning Grant-in-Aid, and Grant-in-Aid, as well as all AHA National funding programs.
The application deadline is FRIDAY, JAN 26TH AT 5:00 PACIFIC STANDARD TIME.
Please contact either Rebecca Hartley or Tom Resta
with any questions or link to: https://research.americanheart.org
Signature Research Programs
Signature Program in Cardiovascular and Metabolic Disease
The Signature Program in Cardiovascular and Metabolic Disease includes
basic, clinical, and translational research, as well as population based
outcomes research and community outreach activities.
The MISSION of the CVMD Signature program is to support and enhance the activities of
investigators at the University of New Mexico Health Sciences Center who are
pursuing important, clinically relevant research questions focusing on
Cardiovascular and Metabolic Disease. This program aims to enhance the
collaborative inter-disciplinary scientific interactions within the institution,
to increase the level of junior faculty mentorship and support and to promote
the development of new areas of research strength.
- To establish an electronic database of cardiovascular and metabolic
disease investigators at the University of New Mexico which will serve
as an information resource for investigators within and outside of the program.
- To support new and emerging areas of research related to cardiovascular
and metabolic disease through the establishment of a pilot project
grants program that will lead to expanded extramurally funded research programs.
- To facilitate the exchange of information and ideas
between investigators in the program through a regular CVMD research seminar series.
- To maintain an up-to-date CVMD webpage with links to relevant CVMD research initiatives.
- Dale Alverson, Pediatrics
- Joe Anderson, Pharmacy
- Amanda Beck, Internal Medicine
- Lee Brown, Internal Medicine and Pediatrics, Director of Program in Sleep Medicine
- Julie Broyles, Internal Medicine
- Mark Burge, Medicine/Endocrinology
- Matthew Campen, Pharmacy
- Kathleen Colleran, Medicine/Endocrinology
- Arup Das, Surgery
- Richard Dorin, Medicine/Endocrinology
- William S. Garver, Biochemistry and Molecular Biology
- Laura Gonzalez-Bosc, Cell Biology and Physiology
- Antoinio Harford, Medicine/Nephrology
- Nikki Jernigan, Cell Biology and Physiology
- Vlad Ianus
- Nancy Kanagy, Cell Biology and Physiology
- Warren Laskey, Medicine/Cardiology
- Paul McGuire, Cell Biology and Physiology
- Wolfgang Mueller, Surgery
- Pope Moseley, Internal Medicine
- Glen Murata, Internal Medicine
- Jay Naik, Lovelace Respiratory Research Institute
- Jim Nawarshas, Pharmacy
- Robin Ohls, Neonatology
- Rob Orlando, Biochemistry and Molecular Biology
- Karlett Parra, Biochemistry and Molecular Biology
- Mark Parshall, School of Nursing
- Gretchen Ray, Pharmacy
- Tom Resta, Cell Biology and Physiology
- Robert Rhyne, Family and Community Medicine
- Mark Rohrscheib, Internal Medicine
- Carlos Roldan, Internal Medicine
- Dave Schade, Medicine/Endocrinology
- Karen Servilla, Medicine/Nephrology
- Vallabh (Raj) Shah, Biochemistry and Molecular Biology
- Yihuan Sun, Medicine/Nephrology
- Robert Taylor, Medicine/Cardiology
- David Vander Jagt, Biochemistry and Molecular Biology
- Mary Vilay, Pharmacy
- Dennis T. Villareal, Geriatrics
- Wyatt Voyles, Medicine/Cardiology
- Benjimen Walker, Cell Biology and Physiology
- Mary Walker, Pharmacy
- Audrey Wells, Internal Medicine
- Cheri Wells, Medicine/Cardiology
- Phil Zager, Medicine/Nephrology
Key Areas of Research Focus
This program is structured to include basic science research, clinical/translational
research and population/outcomes research and community outreach activities.
I. Vascular Remodeling and Altered Vascular Reactivity in conditions
such as Hypertension, Sleep apnea and other hypoxic disorders, Diabetes,
Aging, Heart Disease, Chronic kidney disease and Stroke.
II. Improving the diagnosis and treatment of vascular alterations in
Cerebrovascular, Cardiac and Chronic kidney disease.
III. Population/Outcomes Research and Community Outreach studies focused
on vascular disease surveillance, intervention and education, the prevention
of cardiovascular disease (CVD).
I. Clinical/Translational studies focusing on diabetes diagnosis, management
II. The mechanisms and treatment of diabetic complications including
retinopathy, nephropathy, peripheral vascular disease, heart disease
III. The mechanisms, diagnosis and treatment of chronic kidney diseases
including the role of inflammation and cellular stress.
IV. Basic science investigations of lipoprotein catabolism, adipocyte
differentiation and atherosclerosis.
V. Population/Outcomes Research and Community Outreach studies focused
on diabetes surveillance, intervention and education, the prevention
of obesity and the promotion of healthy lifestyles: nutrition and physical
The various components of the program are supported by grants and
contracts from a variety of sources including the NIH, CDC, EPA, American Heart
Assn., American Diabetes Assn, Agency for Healthcare Research and Quality (AHRQ),
and various pharmaceutical companies. Many of
these grants are interdisciplinary and involve multiple faculty members from
across the Health Sciences Center and the scientific community at large.
The General Clinical Research
Center and the Clinical Trials Center (CTC) is heavily used and supports
many of the clinical/translational studies carried out by investigators
in this program.
The Prevention Research Center
is a long standing center at UNM with extensive outside support from NIH,
CDC, USDA and other sources for conducting community-based intervention
trials, surveillance and translational research addressing the prevention
of diabetes and cardiovascular disease. Education and training includes
community and university-based activities.
Project ECHO (Extension for Community Healthcare Outcomes) is an innovative
healthcare program developed to treat chronic and complex diseases in rural and
underserved areas of New Mexico. Through the use of technology, ECHO bridges the
gap between urban healthcare specialists and providers in rural settings.
Research partnerships with Lovelace Respiratory Research Institute (LRRI) are
important collaborations that have been advancing understanding of cardiopulmonary
disease for the past 20 years. Several LRRI investigators are adjunct faculty
members at UNM and important members of the CVMD Signature Program.
The training activities of the basic science component of the program in Cardiovascular
Disease are supported by an NHLBI training grant in its 15th consecutive year of funding
that includes 19 faculty mentors from the School of Medicine, College of Pharmacy and The
Lovelace Respiratory Research Institute.
Program Steering Committee
Nancy Kanagy: Steering Committee Chair, Department of Cell Biology and Physiology
Joe Anderson: Departments of Pharmacy Practice and Internal Medicine
Matthew Campen: Department of Pharmaceutical Sciences
Kathleen Colleran: Department of Internal Medicine, Endocrinology Division
Vallabh Shah: Department of Biochemistry and Molecular Biology